Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 9.13312738 |
2 | hair cycle (GO:0042633) | 9.05009472 |
3 | molting cycle (GO:0042303) | 9.05009472 |
4 | multicellular organismal water homeostasis (GO:0050891) | 8.79557443 |
5 | epidermal cell differentiation (GO:0009913) | 8.78215812 |
6 | keratinocyte proliferation (GO:0043616) | 7.92655892 |
7 | positive regulation of interleukin-8 secretion (GO:2000484) | 7.74161198 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55993931 |
9 | L-phenylalanine catabolic process (GO:0006559) | 7.55993931 |
10 | regulation of transforming growth factor beta1 production (GO:0032908) | 7.38191719 |
11 | water homeostasis (GO:0030104) | 7.34582860 |
12 | L-phenylalanine metabolic process (GO:0006558) | 7.19370359 |
13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19370359 |
14 | positive regulation of glomerulus development (GO:0090193) | 7.01682364 |
15 | aromatic amino acid family catabolic process (GO:0009074) | 6.91363621 |
16 | epidermis development (GO:0008544) | 6.90695697 |
17 | positive regulation of humoral immune response (GO:0002922) | 6.73609372 |
18 | peptide cross-linking (GO:0018149) | 6.73592732 |
19 | indole-containing compound catabolic process (GO:0042436) | 6.39202197 |
20 | indolalkylamine catabolic process (GO:0046218) | 6.39202197 |
21 | tryptophan catabolic process (GO:0006569) | 6.39202197 |
22 | defense response to Gram-negative bacterium (GO:0050829) | 6.32097223 |
23 | kynurenine metabolic process (GO:0070189) | 6.25951143 |
24 | bile acid biosynthetic process (GO:0006699) | 6.25028302 |
25 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.15894502 |
26 | positive regulation of p38MAPK cascade (GO:1900745) | 6.03984087 |
27 | regulation of cell proliferation involved in kidney development (GO:1901722) | 6.01471377 |
28 | tryptophan metabolic process (GO:0006568) | 5.99633596 |
29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.92632148 |
30 | defense response to fungus (GO:0050832) | 5.87324607 |
31 | glyoxylate metabolic process (GO:0046487) | 5.84847195 |
32 | complement activation, alternative pathway (GO:0006957) | 5.76859024 |
33 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.68620560 |
34 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 5.64615648 |
35 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 5.64615648 |
36 | regulation of protein activation cascade (GO:2000257) | 5.63632590 |
37 | urea cycle (GO:0000050) | 5.60830029 |
38 | urea metabolic process (GO:0019627) | 5.60830029 |
39 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.58906067 |
40 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54190459 |
41 | cysteine metabolic process (GO:0006534) | 5.48429489 |
42 | regulation of cellular amide metabolic process (GO:0034248) | 5.47588424 |
43 | negative regulation of fibrinolysis (GO:0051918) | 5.45682298 |
44 | protein carboxylation (GO:0018214) | 5.37294109 |
45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37294109 |
46 | regulation of fibrinolysis (GO:0051917) | 5.34746221 |
47 | regulation of complement activation (GO:0030449) | 5.33500823 |
48 | sulfur amino acid catabolic process (GO:0000098) | 5.32532672 |
49 | lipoxygenase pathway (GO:0019372) | 5.31569441 |
50 | antimicrobial humoral response (GO:0019730) | 5.31363078 |
51 | high-density lipoprotein particle remodeling (GO:0034375) | 5.27470510 |
52 | bile acid metabolic process (GO:0008206) | 5.19846094 |
53 | nitrogen cycle metabolic process (GO:0071941) | 5.16374470 |
54 | regulation of interleukin-8 secretion (GO:2000482) | 5.15481279 |
55 | detection of bacterium (GO:0016045) | 5.13695062 |
56 | skin morphogenesis (GO:0043589) | 5.12116989 |
57 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.10139617 |
58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.07840320 |
59 | serine family amino acid catabolic process (GO:0009071) | 5.04411170 |
60 | aromatic amino acid family metabolic process (GO:0009072) | 5.00576261 |
61 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.98783412 |
62 | intermediate filament organization (GO:0045109) | 4.92587256 |
63 | linoleic acid metabolic process (GO:0043651) | 4.88622458 |
64 | negative regulation of interleukin-17 production (GO:0032700) | 4.87162273 |
65 | homocysteine metabolic process (GO:0050667) | 4.82809512 |
66 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.81715116 |
67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.77069333 |
68 | intermediate filament cytoskeleton organization (GO:0045104) | 4.75590284 |
69 | regulation of triglyceride catabolic process (GO:0010896) | 4.73293911 |
70 | tyrosine metabolic process (GO:0006570) | 4.68407385 |
71 | coenzyme catabolic process (GO:0009109) | 4.66797648 |
72 | ectoderm development (GO:0007398) | 4.65990127 |
73 | alpha-amino acid catabolic process (GO:1901606) | 4.64581484 |
74 | detection of other organism (GO:0098543) | 4.64454837 |
75 | lysine catabolic process (GO:0006554) | 4.62131792 |
76 | lysine metabolic process (GO:0006553) | 4.62131792 |
77 | intermediate filament-based process (GO:0045103) | 4.60389849 |
78 | fatty acid elongation (GO:0030497) | 4.60368837 |
79 | reverse cholesterol transport (GO:0043691) | 4.58101854 |
80 | triglyceride homeostasis (GO:0070328) | 4.57483018 |
81 | acylglycerol homeostasis (GO:0055090) | 4.57483018 |
82 | phospholipid efflux (GO:0033700) | 4.55743279 |
83 | regulation of glomerulus development (GO:0090192) | 4.51940425 |
84 | indolalkylamine metabolic process (GO:0006586) | 4.51771988 |
85 | protein-lipid complex remodeling (GO:0034368) | 4.50832103 |
86 | macromolecular complex remodeling (GO:0034367) | 4.50832103 |
87 | plasma lipoprotein particle remodeling (GO:0034369) | 4.50832103 |
88 | bile acid and bile salt transport (GO:0015721) | 4.50660700 |
89 | amino-acid betaine metabolic process (GO:0006577) | 4.49446055 |
90 | glycine metabolic process (GO:0006544) | 4.49049551 |
91 | imidazole-containing compound metabolic process (GO:0052803) | 4.48170226 |
92 | regulation of cholesterol esterification (GO:0010872) | 4.44157426 |
93 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.42750185 |
94 | regulation of p38MAPK cascade (GO:1900744) | 4.42703481 |
95 | cellular biogenic amine catabolic process (GO:0042402) | 4.42611714 |
96 | amine catabolic process (GO:0009310) | 4.42611714 |
97 | negative regulation of interferon-gamma production (GO:0032689) | 4.39413279 |
98 | surfactant homeostasis (GO:0043129) | 4.32591246 |
99 | negative regulation of sterol transport (GO:0032372) | 4.30404587 |
100 | negative regulation of cholesterol transport (GO:0032375) | 4.30404587 |
101 | cellular ketone body metabolic process (GO:0046950) | 4.30356831 |
102 | glutamate metabolic process (GO:0006536) | 4.28563414 |
103 | cellular amino acid catabolic process (GO:0009063) | 4.28496230 |
104 | cytolysis (GO:0019835) | 4.27581018 |
105 | cellular glucuronidation (GO:0052695) | 4.26242639 |
106 | serine family amino acid metabolic process (GO:0009069) | 4.24612658 |
107 | ethanol oxidation (GO:0006069) | 4.23136386 |
108 | cellular modified amino acid catabolic process (GO:0042219) | 4.16330234 |
109 | plasma lipoprotein particle clearance (GO:0034381) | 4.16081502 |
110 | benzene-containing compound metabolic process (GO:0042537) | 4.10699995 |
111 | chemical homeostasis within a tissue (GO:0048875) | 4.09382886 |
112 | fibrinolysis (GO:0042730) | 4.09094213 |
113 | serine family amino acid biosynthetic process (GO:0009070) | 4.08360319 |
114 | positive regulation of transforming growth factor beta production (GO:0071636) | 4.06929284 |
115 | activation of MAPKKK activity (GO:0000185) | 4.05426233 |
116 | complement activation, classical pathway (GO:0006958) | 4.03739686 |
117 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02939703 |
118 | cholesterol efflux (GO:0033344) | 4.02368451 |
119 | response to fungus (GO:0009620) | 4.02028058 |
120 | positive regulation of epidermis development (GO:0045684) | 4.00260458 |
121 | positive regulation of cholesterol efflux (GO:0010875) | 3.99192625 |
122 | complement activation (GO:0006956) | 3.97395922 |
123 | regulation of natural killer cell differentiation (GO:0032823) | 3.93598611 |
124 | aldehyde catabolic process (GO:0046185) | 3.89220908 |
125 | arginine metabolic process (GO:0006525) | 3.86510995 |
126 | protein activation cascade (GO:0072376) | 3.84676704 |
127 | cofactor catabolic process (GO:0051187) | 3.81655015 |
128 | acetyl-CoA metabolic process (GO:0006084) | 3.79965651 |
129 | uronic acid metabolic process (GO:0006063) | 3.77954122 |
130 | glucuronate metabolic process (GO:0019585) | 3.77954122 |
131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77880345 |
132 | antibacterial humoral response (GO:0019731) | 3.77441543 |
133 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77412317 |
134 | ceramide biosynthetic process (GO:0046513) | 3.75484134 |
135 | regulation of cholesterol homeostasis (GO:2000188) | 3.75000203 |
136 | plasma lipoprotein particle assembly (GO:0034377) | 3.74931214 |
137 | organic acid catabolic process (GO:0016054) | 3.73528259 |
138 | carboxylic acid catabolic process (GO:0046395) | 3.73528259 |
139 | ketone body metabolic process (GO:1902224) | 3.72385351 |
140 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.72348533 |
141 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.71476137 |
142 | natural killer cell activation involved in immune response (GO:0002323) | 3.71466518 |
143 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68029284 |
144 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68029284 |
145 | keratinocyte development (GO:0003334) | 3.68022048 |
146 | regulation of T-helper 1 type immune response (GO:0002825) | 3.67716034 |
147 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.66271953 |
148 | positive regulation of response to biotic stimulus (GO:0002833) | 3.65980175 |
149 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63764435 |
150 | cholesterol homeostasis (GO:0042632) | 3.63569601 |
151 | phospholipid homeostasis (GO:0055091) | 3.62802488 |
152 | dendritic cell migration (GO:0036336) | 3.57787704 |
153 | sterol homeostasis (GO:0055092) | 3.57355008 |
154 | intestinal cholesterol absorption (GO:0030299) | 3.57229215 |
155 | negative regulation of lipase activity (GO:0060192) | 3.56298770 |
156 | positive regulation of lipid catabolic process (GO:0050996) | 3.56032927 |
157 | positive regulation of sterol transport (GO:0032373) | 3.55498906 |
158 | positive regulation of cholesterol transport (GO:0032376) | 3.55498906 |
159 | short-chain fatty acid metabolic process (GO:0046459) | 3.52989586 |
160 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.52453907 |
161 | NAD biosynthetic process (GO:0009435) | 3.51655664 |
162 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49755794 |
163 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.49755794 |
164 | aspartate family amino acid catabolic process (GO:0009068) | 3.47321342 |
165 | regulation of neuron projection regeneration (GO:0070570) | 3.43960912 |
166 | regulation of axon regeneration (GO:0048679) | 3.43960912 |
167 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.41380663 |
168 | phosphatidylserine metabolic process (GO:0006658) | 3.38258174 |
169 | positive regulation of meiotic cell cycle (GO:0051446) | 3.29996550 |
170 | epithelium development (GO:0060429) | 3.14790940 |
171 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.13565183 |
172 | regulation of hair cycle (GO:0042634) | 3.11190365 |
173 | establishment of planar polarity (GO:0001736) | 3.09818358 |
174 | establishment of tissue polarity (GO:0007164) | 3.09818358 |
175 | hemidesmosome assembly (GO:0031581) | 3.05546624 |
176 | gap junction assembly (GO:0016264) | 3.01317854 |
177 | keratinization (GO:0031424) | 27.4638434 |
178 | cellular response to arsenic-containing substance (GO:0071243) | 2.97133893 |
179 | negative regulation of meiotic cell cycle (GO:0051447) | 2.95308171 |
180 | regulation of epidermis development (GO:0045682) | 2.94542312 |
181 | hair cell differentiation (GO:0035315) | 2.92236621 |
182 | positive regulation of interleukin-6 production (GO:0032755) | 2.88788416 |
183 | regulation of keratinocyte differentiation (GO:0045616) | 2.85451095 |
184 | regulation of transforming growth factor beta production (GO:0071634) | 2.76460026 |
185 | defense response to Gram-positive bacterium (GO:0050830) | 2.75489654 |
186 | phospholipid catabolic process (GO:0009395) | 2.72030429 |
187 | regulation of collagen biosynthetic process (GO:0032965) | 2.70969375 |
188 | alditol phosphate metabolic process (GO:0052646) | 2.68351317 |
189 | regulation of ruffle assembly (GO:1900027) | 2.68039779 |
190 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.62781000 |
191 | early endosome to late endosome transport (GO:0045022) | 2.59926894 |
192 | regulation of interleukin-17 production (GO:0032660) | 2.54098930 |
193 | regulation of interleukin-6 production (GO:0032675) | 2.51760793 |
194 | regulation of cholesterol efflux (GO:0010874) | 2.50981807 |
195 | establishment of skin barrier (GO:0061436) | 16.2449685 |
196 | regulation of water loss via skin (GO:0033561) | 13.9973228 |
197 | positive regulation of cellular amide metabolic process (GO:0034250) | 10.6594156 |
198 | keratinocyte differentiation (GO:0030216) | 10.2741030 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.14598207 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.07191261 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01224113 |
4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 6.98285747 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.34307830 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24960341 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85782217 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.56720967 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99543110 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.75678930 |
11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.34253328 |
12 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 3.18655428 |
13 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 3.18655428 |
14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.62032796 |
15 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.25697509 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7006859 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97290660 |
18 | RXR_22108803_ChIP-Seq_LS180_Human | 1.92467827 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90169479 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88206606 |
21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.82122686 |
22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67575930 |
23 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.66244491 |
24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65237076 |
25 | ATF3_27146783_Chip-Seq_COLON_Human | 1.64172525 |
26 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.59791764 |
27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58378863 |
28 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.53170780 |
29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47606481 |
30 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41860622 |
31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40634967 |
32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40513918 |
33 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34389139 |
34 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32227630 |
35 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30552277 |
36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28735217 |
37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27979140 |
38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27345045 |
39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27100228 |
40 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24534032 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23871175 |
42 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20197013 |
43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19867589 |
44 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18844945 |
45 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17223823 |
46 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17037411 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14854042 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14490458 |
49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13734152 |
50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13145386 |
51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11919379 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09059754 |
53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07189836 |
54 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.06830360 |
55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05261673 |
56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02490146 |
57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02307606 |
58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01086800 |
59 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99790517 |
60 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97274805 |
61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96754990 |
62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94991036 |
63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91784325 |
64 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91742173 |
65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91592833 |
66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90416295 |
67 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90329492 |
68 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90196634 |
69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89452851 |
70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87579503 |
71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87036272 |
72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85910681 |
73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84563963 |
74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84275362 |
75 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84109851 |
76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83602691 |
77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83307457 |
78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80354735 |
79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79126830 |
80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78454672 |
81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77077226 |
82 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76904023 |
83 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75975822 |
84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75281607 |
85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75163922 |
86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73933748 |
87 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.72696616 |
88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72557059 |
89 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72463200 |
90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72102945 |
91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72102945 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70787752 |
93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69481739 |
94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69309459 |
95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69076139 |
96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68890227 |
97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67824413 |
98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67536152 |
99 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.66643226 |
100 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66627636 |
101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66311450 |
102 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66214406 |
103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65903344 |
104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.65803226 |
105 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.64756480 |
106 | * MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.64727215 |
107 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64705922 |
108 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.64474979 |
109 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.64307598 |
110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64140254 |
111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63846349 |
112 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63211411 |
113 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.63043074 |
114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62659733 |
115 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.61828721 |
116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.61813296 |
117 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.61573175 |
118 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.61421610 |
119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60950803 |
120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60173715 |
121 | NCOR_22424771_ChIP-Seq_293T_Human | 0.58333880 |
122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56416427 |
123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55873085 |
124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54487700 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54227427 |
126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53859321 |
127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53372366 |
128 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52231678 |
129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.52006281 |
130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51646362 |
131 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50780032 |
132 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50637277 |
133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50176926 |
134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49907820 |
135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47945510 |
136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47911222 |
137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.47908704 |
138 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47708157 |
139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47476169 |
140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47404890 |
141 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46126980 |
142 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.45608985 |
143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45186553 |
144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44264801 |
145 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44126529 |
146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43391322 |
147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42717979 |
148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42242719 |
149 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42222876 |
150 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.41968329 |
151 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40398283 |
152 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.39764975 |
153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38894754 |
154 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38892915 |
155 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37360054 |
156 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.37071487 |
157 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36845823 |
158 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.36509578 |
159 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36489185 |
160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.36327453 |
161 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36123840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.13114557 |
2 | MP0005360_urolithiasis | 7.36398976 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.46600821 |
4 | MP0005365_abnormal_bile_salt | 6.22370852 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.64692143 |
6 | MP0003941_abnormal_skin_development | 4.43908342 |
7 | MP0003806_abnormal_nucleotide_metabolis | 4.32242752 |
8 | MP0003252_abnormal_bile_duct | 3.92158671 |
9 | MP0010329_abnormal_lipoprotein_level | 3.45568179 |
10 | MP0010678_abnormal_skin_adnexa | 3.43322846 |
11 | MP0005083_abnormal_biliary_tract | 3.20651643 |
12 | MP0009840_abnormal_foam_cell | 2.93526696 |
13 | MP0001666_abnormal_nutrient_absorption | 2.87607389 |
14 | MP0003195_calcinosis | 2.68185437 |
15 | MP0000383_abnormal_hair_follicle | 2.63455590 |
16 | MP0002098_abnormal_vibrissa_morphology | 2.63190326 |
17 | MP0005332_abnormal_amino_acid | 2.60385595 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.40420398 |
19 | MP0000609_abnormal_liver_physiology | 2.09625815 |
20 | MP0002118_abnormal_lipid_homeostasis | 2.07856601 |
21 | MP0003868_abnormal_feces_composition | 2.03732220 |
22 | MP0004019_abnormal_vitamin_homeostasis | 1.97611107 |
23 | MP0002138_abnormal_hepatobiliary_system | 1.84687884 |
24 | MP0003950_abnormal_plasma_membrane | 1.81954826 |
25 | MP0005451_abnormal_body_composition | 1.80252366 |
26 | MP0005319_abnormal_enzyme/_coenzyme | 1.75241328 |
27 | MP0002796_impaired_skin_barrier | 1.54421944 |
28 | MP0001764_abnormal_homeostasis | 1.53919625 |
29 | MP0001188_hyperpigmentation | 1.53411227 |
30 | MP0009697_abnormal_copulation | 1.45475931 |
31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45338323 |
32 | MP0000566_synostosis | 1.44256207 |
33 | MP0005377_hearing/vestibular/ear_phenot | 1.43505587 |
34 | MP0003878_abnormal_ear_physiology | 1.43505587 |
35 | MP0000367_abnormal_coat/_hair | 1.43016857 |
36 | MP0003705_abnormal_hypodermis_morpholog | 1.42723688 |
37 | MP0004885_abnormal_endolymph | 1.38445497 |
38 | MP0000762_abnormal_tongue_morphology | 1.38402926 |
39 | MP0003011_delayed_dark_adaptation | 1.35932110 |
40 | MP0002254_reproductive_system_inflammat | 1.29182907 |
41 | MP0005647_abnormal_sex_gland | 1.22257785 |
42 | MP0001191_abnormal_skin_condition | 1.17506419 |
43 | MP0004381_abnormal_hair_follicle | 1.15526594 |
44 | MP0003186_abnormal_redox_activity | 1.15356284 |
45 | MP0009643_abnormal_urine_homeostasis | 1.12344732 |
46 | MP0005409_darkened_coat_color | 1.11825607 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.11311316 |
48 | MP0000598_abnormal_liver_morphology | 1.09411209 |
49 | MP0004264_abnormal_extraembryonic_tissu | 1.03052571 |
50 | MP0000579_abnormal_nail_morphology | 1.02051892 |
51 | MP0002095_abnormal_skin_pigmentation | 0.99351617 |
52 | MP0000604_amyloidosis | 0.98468494 |
53 | MP0009764_decreased_sensitivity_to | 0.97920964 |
54 | MP0010368_abnormal_lymphatic_system | 0.94786041 |
55 | MP0009763_increased_sensitivity_to | 0.94217789 |
56 | MP0005220_abnormal_exocrine_pancreas | 0.90747046 |
57 | MP0004185_abnormal_adipocyte_glucose | 0.89780245 |
58 | MP0003566_abnormal_cell_adhesion | 0.85813349 |
59 | MP0005636_abnormal_mineral_homeostasis | 0.85552433 |
60 | MP0008004_abnormal_stomach_pH | 0.84484969 |
61 | MP0010234_abnormal_vibrissa_follicle | 0.84408337 |
62 | MP0001784_abnormal_fluid_regulation | 0.84021883 |
63 | MP0008469_abnormal_protein_level | 0.83939743 |
64 | MP0005084_abnormal_gallbladder_morpholo | 0.81306851 |
65 | MP0005408_hypopigmentation | 0.81188443 |
66 | MP0009642_abnormal_blood_homeostasis | 0.79969132 |
67 | MP0002876_abnormal_thyroid_physiology | 0.77291346 |
68 | MP0000465_gastrointestinal_hemorrhage | 0.76363814 |
69 | MP0010352_gastrointestinal_tract_polyps | 0.75320717 |
70 | MP0005501_abnormal_skin_physiology | 0.73461024 |
71 | MP0009765_abnormal_xenobiotic_induced | 0.73107348 |
72 | MP0006036_abnormal_mitochondrial_physio | 0.72783296 |
73 | MP0002078_abnormal_glucose_homeostasis | 0.72157377 |
74 | MP0005376_homeostasis/metabolism_phenot | 0.70609693 |
75 | MP0002971_abnormal_brown_adipose | 0.70389360 |
76 | MP0005670_abnormal_white_adipose | 0.68991743 |
77 | MP0005535_abnormal_body_temperature | 0.67866491 |
78 | MP0004130_abnormal_muscle_cell | 0.66978690 |
79 | MP0005334_abnormal_fat_pad | 0.66613295 |
80 | MP0004272_abnormal_basement_membrane | 0.65111815 |
81 | MP0002060_abnormal_skin_morphology | 0.64520245 |
82 | MP0001851_eye_inflammation | 0.64304147 |
83 | MP0003329_amyloid_beta_deposits | 0.62579495 |
84 | MP0004043_abnormal_pH_regulation | 0.61635264 |
85 | MP0009053_abnormal_anal_canal | 0.61090076 |
86 | MP0003690_abnormal_glial_cell | 0.59633561 |
87 | MP0001661_extended_life_span | 0.59540323 |
88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59431866 |
89 | MP0005266_abnormal_metabolism | 0.58588976 |
90 | MP0004782_abnormal_surfactant_physiolog | 0.58226194 |
91 | MP0004947_skin_inflammation | 0.57262440 |
92 | MP0005448_abnormal_energy_balance | 0.56051304 |
93 | MP0005275_abnormal_skin_tensile | 0.55718836 |
94 | MP0005023_abnormal_wound_healing | 0.55134362 |
95 | MP0000427_abnormal_hair_cycle | 0.54989644 |
96 | MP0001177_atelectasis | 0.53970316 |
97 | MP0000015_abnormal_ear_pigmentation | 0.53505219 |
98 | MP0006035_abnormal_mitochondrial_morpho | 0.53129790 |
99 | MP0000639_abnormal_adrenal_gland | 0.51926559 |
100 | MP0009384_cardiac_valve_regurgitation | 0.51729015 |
101 | MP0002234_abnormal_pharynx_morphology | 0.50775528 |
102 | MP0003453_abnormal_keratinocyte_physiol | 0.50352230 |
103 | MP0005174_abnormal_tail_pigmentation | 0.49366917 |
104 | MP0000647_abnormal_sebaceous_gland | 0.47305252 |
105 | MP0001216_abnormal_epidermal_layer | 0.47017282 |
106 | MP0001756_abnormal_urination | 0.45902512 |
107 | MP0003638_abnormal_response/metabolism_ | 0.45380106 |
108 | MP0001340_abnormal_eyelid_morphology | 0.44967923 |
109 | MP0001243_abnormal_dermal_layer | 0.42974340 |
110 | MP0002928_abnormal_bile_duct | 0.42427212 |
111 | MP0002822_catalepsy | 0.41949869 |
112 | MP0005666_abnormal_adipose_tissue | 0.41896155 |
113 | MP0003724_increased_susceptibility_to | 0.41286927 |
114 | MP0002177_abnormal_outer_ear | 0.40951772 |
115 | MP0000377_abnormal_hair_follicle | 0.40762442 |
116 | MP0005395_other_phenotype | 0.40299295 |
117 | MP0005166_decreased_susceptibility_to | 0.40058838 |
118 | MP0009379_abnormal_foot_pigmentation | 0.39447037 |
119 | MP0003718_maternal_effect | 0.39350453 |
120 | MP0003828_pulmonary_edema | 0.38701716 |
121 | MP0008873_increased_physiological_sensi | 0.38362917 |
122 | MP0003075_altered_response_to | 0.38163893 |
123 | MP0005075_abnormal_melanosome_morpholog | 0.38096488 |
124 | MP0005464_abnormal_platelet_physiology | 0.37535188 |
125 | MP0005248_abnormal_Harderian_gland | 0.36659015 |
126 | MP0008874_decreased_physiological_sensi | 0.36583688 |
127 | MP0004510_myositis | 0.36475998 |
128 | MP0002136_abnormal_kidney_physiology | 0.36306716 |
129 | MP0009672_abnormal_birth_weight | 0.36019586 |
130 | MP0003953_abnormal_hormone_level | 0.35727059 |
131 | MP0009931_abnormal_skin_appearance | 0.35159665 |
132 | MP0003436_decreased_susceptibility_to | 0.35141828 |
133 | MP0002837_dystrophic_cardiac_calcinosis | 0.34967299 |
134 | MP0008057_abnormal_DNA_replication | 0.34533265 |
135 | MP0000467_abnormal_esophagus_morphology | 0.34006260 |
136 | MP0010771_integument_phenotype | 0.33949574 |
137 | MP0002009_preneoplasia | 0.33550888 |
138 | MP0003755_abnormal_palate_morphology | 0.32757399 |
139 | MP0005375_adipose_tissue_phenotype | 0.30694054 |
140 | MP0002133_abnormal_respiratory_system | 0.30196233 |
141 | MP0005388_respiratory_system_phenotype | 0.30196233 |
142 | MP0009333_abnormal_splenocyte_physiolog | 0.28221124 |
143 | MP0003315_abnormal_perineum_morphology | 0.27442091 |
144 | MP0004197_abnormal_fetal_growth/weight/ | 0.26813912 |
145 | MP0008995_early_reproductive_senescence | 0.25519805 |
146 | MP0002111_abnormal_tail_morphology | 0.24739355 |
147 | MP0010030_abnormal_orbit_morphology | 0.22823939 |
148 | MP0002697_abnormal_eye_size | 0.22472958 |
149 | MP0001502_abnormal_circadian_rhythm | 0.21976778 |
150 | MP0000627_abnormal_mammary_gland | 0.21506568 |
151 | MP0005171_absent_coat_pigmentation | 0.19991933 |
152 | MP0001984_abnormal_olfaction | 0.19721639 |
153 | MP0002295_abnormal_pulmonary_circulatio | 0.16617526 |
154 | MP0002877_abnormal_melanocyte_morpholog | 0.15858367 |
155 | MP0000470_abnormal_stomach_morphology | 0.13475977 |
156 | MP0005076_abnormal_cell_differentiation | 0.12442307 |
157 | MP0005503_abnormal_tendon_morphology | 0.12147187 |
158 | MP0001186_pigmentation_phenotype | 0.11761400 |
159 | MP0006072_abnormal_retinal_apoptosis | 0.10986921 |
160 | MP0008789_abnormal_olfactory_epithelium | 0.10981339 |
161 | MP0000003_abnormal_adipose_tissue | 0.10810890 |
162 | MP0003763_abnormal_thymus_physiology | 0.10111133 |
163 | MP0005193_abnormal_anterior_eye | 0.09450198 |
164 | MP0000432_abnormal_head_morphology | 0.08352975 |
165 | MP0005508_abnormal_skeleton_morphology | 0.07683891 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased IgE level (HP:0003212) | 9.77893856 |
2 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 9.29798296 |
3 | Congenital ichthyosiform erythroderma (HP:0007431) | 9.04145778 |
4 | Palmoplantar hyperkeratosis (HP:0000972) | 8.69736302 |
5 | Parakeratosis (HP:0001036) | 8.53880554 |
6 | Palmar hyperkeratosis (HP:0010765) | 8.27380634 |
7 | Erythroderma (HP:0001019) | 8.08286095 |
8 | Intrahepatic cholestasis (HP:0001406) | 7.73708700 |
9 | Deep venous thrombosis (HP:0002625) | 7.33930665 |
10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23061365 |
11 | Oral leukoplakia (HP:0002745) | 7.17561307 |
12 | Plantar hyperkeratosis (HP:0007556) | 7.02125308 |
13 | Erythema (HP:0010783) | 6.68722802 |
14 | Prolonged partial thromboplastin time (HP:0003645) | 6.57500567 |
15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.53981214 |
16 | Thick nail (HP:0001805) | 6.27327018 |
17 | Hypobetalipoproteinemia (HP:0003563) | 6.25094905 |
18 | Xanthomatosis (HP:0000991) | 6.24374318 |
19 | Complement deficiency (HP:0004431) | 6.10193436 |
20 | Hypotrichosis (HP:0001006) | 5.41844766 |
21 | Onycholysis (HP:0001806) | 5.41523198 |
22 | Hyperlipoproteinemia (HP:0010980) | 5.35977838 |
23 | Corneal erosion (HP:0200020) | 5.30113349 |
24 | Ectropion (HP:0000656) | 4.68002309 |
25 | Epidermoid cyst (HP:0200040) | 4.67225392 |
26 | Palmoplantar keratoderma (HP:0000982) | 4.66963193 |
27 | Joint hemorrhage (HP:0005261) | 4.64351419 |
28 | Hypolipoproteinemia (HP:0010981) | 4.63750721 |
29 | Fat malabsorption (HP:0002630) | 4.53551271 |
30 | Hyperglycinemia (HP:0002154) | 4.51909638 |
31 | Follicular hyperkeratosis (HP:0007502) | 4.51444448 |
32 | Abnormality of complement system (HP:0005339) | 4.49026620 |
33 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47965602 |
34 | Gangrene (HP:0100758) | 4.47130221 |
35 | Hypohidrosis (HP:0000966) | 4.47061556 |
36 | Hyperammonemia (HP:0001987) | 4.46989256 |
37 | Alopecia of scalp (HP:0002293) | 4.41263492 |
38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24087226 |
39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15654304 |
40 | Ketosis (HP:0001946) | 4.14669985 |
41 | Abnormality of methionine metabolism (HP:0010901) | 4.06849007 |
42 | Fragile nails (HP:0001808) | 4.01384509 |
43 | Abnormality of the axillary hair (HP:0100134) | 4.01051444 |
44 | Abnormality of secondary sexual hair (HP:0009888) | 4.01051444 |
45 | Hypoalphalipoproteinemia (HP:0003233) | 4.00039594 |
46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95079497 |
47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92061519 |
48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.89854092 |
49 | Nail dystrophy (HP:0008404) | 3.88583551 |
50 | Conjugated hyperbilirubinemia (HP:0002908) | 3.88499370 |
51 | Abnormality of glycine metabolism (HP:0010895) | 3.87589141 |
52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87589141 |
53 | Hyperglycinuria (HP:0003108) | 3.83050724 |
54 | Hypoglycemic coma (HP:0001325) | 3.78068316 |
55 | Lip pit (HP:0100267) | 3.71813882 |
56 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59815599 |
57 | Pustule (HP:0200039) | 3.57467553 |
58 | Steatorrhea (HP:0002570) | 3.55962066 |
59 | Hypercholesterolemia (HP:0003124) | 3.41621788 |
60 | Pruritus (HP:0000989) | 3.38949400 |
61 | Conjunctival hamartoma (HP:0100780) | 3.32721497 |
62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29127807 |
63 | Woolly hair (HP:0002224) | 3.27070517 |
64 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24337366 |
65 | Hyperbilirubinemia (HP:0002904) | 3.21442359 |
66 | Right ventricular cardiomyopathy (HP:0011663) | 3.19721501 |
67 | Sparse scalp hair (HP:0002209) | 3.14587482 |
68 | Abnormal blistering of the skin (HP:0008066) | 3.12285547 |
69 | Hypochromic microcytic anemia (HP:0004840) | 3.08198690 |
70 | Myocardial infarction (HP:0001658) | 3.05339331 |
71 | Delayed CNS myelination (HP:0002188) | 3.02954558 |
72 | Abnormality of serum amino acid levels (HP:0003112) | 3.00730011 |
73 | Systemic lupus erythematosus (HP:0002725) | 2.98983066 |
74 | Ketoacidosis (HP:0001993) | 2.94244907 |
75 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93645823 |
76 | Hyperhidrosis (HP:0000975) | 2.93296644 |
77 | Abnormality of the salivary glands (HP:0010286) | 2.92067728 |
78 | Hepatocellular carcinoma (HP:0001402) | 2.91976695 |
79 | Spontaneous abortion (HP:0005268) | 2.88852214 |
80 | Laryngomalacia (HP:0001601) | 2.85177213 |
81 | Skin nodule (HP:0200036) | 2.83741318 |
82 | Lack of skin elasticity (HP:0100679) | 2.81374539 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74590658 |
84 | Furrowed tongue (HP:0000221) | 2.71227456 |
85 | Metabolic acidosis (HP:0001942) | 2.65416253 |
86 | Abnormality of purine metabolism (HP:0004352) | 2.60560935 |
87 | Sparse eyelashes (HP:0000653) | 2.57410723 |
88 | Absent eyelashes (HP:0000561) | 2.56199756 |
89 | Dehydration (HP:0001944) | 2.55721608 |
90 | Vascular calcification (HP:0004934) | 2.54799099 |
91 | Neonatal onset (HP:0003623) | 2.52021961 |
92 | Natal tooth (HP:0000695) | 2.50737857 |
93 | Hypergammaglobulinemia (HP:0010702) | 2.50214646 |
94 | Lethargy (HP:0001254) | 2.49301450 |
95 | Abnormal gallbladder morphology (HP:0012437) | 2.48980203 |
96 | Gout (HP:0001997) | 2.48743622 |
97 | Acanthocytosis (HP:0001927) | 2.48027408 |
98 | Corneal dystrophy (HP:0001131) | 2.47034253 |
99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46345687 |
100 | Dicarboxylic aciduria (HP:0003215) | 2.46345687 |
101 | Spastic diplegia (HP:0001264) | 2.44165393 |
102 | Cholelithiasis (HP:0001081) | 2.43972337 |
103 | Hypoglycemic seizures (HP:0002173) | 2.43150584 |
104 | Brittle hair (HP:0002299) | 2.40210583 |
105 | Mitral stenosis (HP:0001718) | 2.36544443 |
106 | Malnutrition (HP:0004395) | 2.32627217 |
107 | Abnormal gallbladder physiology (HP:0012438) | 2.31894680 |
108 | Cholecystitis (HP:0001082) | 2.31894680 |
109 | Cerebral edema (HP:0002181) | 2.31828984 |
110 | Eczematoid dermatitis (HP:0000976) | 2.31406476 |
111 | Absent hair (HP:0002298) | 2.30074530 |
112 | Cardiovascular calcification (HP:0011915) | 2.26115289 |
113 | Sensorimotor neuropathy (HP:0007141) | 2.23438918 |
114 | Irritability (HP:0000737) | 2.22800453 |
115 | Amyloidosis (HP:0011034) | 2.21924915 |
116 | Glomerulonephritis (HP:0000099) | 2.21690962 |
117 | Pancreatitis (HP:0001733) | 2.19055386 |
118 | Hamartoma of the eye (HP:0010568) | 2.16417532 |
119 | Brushfield spots (HP:0001088) | 2.11174252 |
120 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.10723141 |
121 | Villous atrophy (HP:0011473) | 2.10723141 |
122 | Late onset (HP:0003584) | 2.10513103 |
123 | Esophageal varix (HP:0002040) | 2.10164195 |
124 | Gingival bleeding (HP:0000225) | 2.09859540 |
125 | Opisthotonus (HP:0002179) | 2.06007500 |
126 | Pili torti (HP:0003777) | 2.05813017 |
127 | Abnormality of the gallbladder (HP:0005264) | 2.05131758 |
128 | Menorrhagia (HP:0000132) | 2.04375198 |
129 | Enlarged kidneys (HP:0000105) | 2.02919684 |
130 | Anonychia (HP:0001798) | 2.01472992 |
131 | Abnormality of nail color (HP:0100643) | 14.0375857 |
132 | Hemorrhage of the eye (HP:0011885) | 1.99722653 |
133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98996445 |
134 | Vomiting (HP:0002013) | 1.98852490 |
135 | Advanced eruption of teeth (HP:0006288) | 1.98488266 |
136 | Thrombophlebitis (HP:0004418) | 1.97053456 |
137 | Rickets (HP:0002748) | 1.96260123 |
138 | Blepharitis (HP:0000498) | 1.93774472 |
139 | Generalized aminoaciduria (HP:0002909) | 1.91760864 |
140 | Abnormal hair laboratory examination (HP:0003328) | 1.91100742 |
141 | Dry skin (HP:0000958) | 1.90566014 |
142 | Dry hair (HP:0011359) | 1.88760553 |
143 | Sepsis (HP:0100806) | 1.88477778 |
144 | Renal cortical cysts (HP:0000803) | 1.87445572 |
145 | Acanthosis nigricans (HP:0000956) | 1.87116176 |
146 | Urticaria (HP:0001025) | 1.86730164 |
147 | Hypophosphatemic rickets (HP:0004912) | 1.86073562 |
148 | Abnormal cartilage morphology (HP:0002763) | 1.84848013 |
149 | Poikilocytosis (HP:0004447) | 1.84492245 |
150 | Milia (HP:0001056) | 1.84260684 |
151 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84033751 |
152 | Abnormality of iron homeostasis (HP:0011031) | 1.79504698 |
153 | Verrucae (HP:0200043) | 1.79070954 |
154 | Papilloma (HP:0012740) | 1.79070954 |
155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78506592 |
156 | Elevated hepatic transaminases (HP:0002910) | 1.78214163 |
157 | Amniotic constriction ring (HP:0009775) | 1.74718521 |
158 | Abnormality of placental membranes (HP:0011409) | 1.74718521 |
159 | Carious teeth (HP:0000670) | 1.73967898 |
160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73781623 |
161 | Abnormality of vitamin metabolism (HP:0100508) | 1.73147968 |
162 | Hyperglycemia (HP:0003074) | 1.73120302 |
163 | Skin ulcer (HP:0200042) | 1.72982912 |
164 | Hypoplastic labia majora (HP:0000059) | 1.72181164 |
165 | Status epilepticus (HP:0002133) | 1.71708924 |
166 | Distal lower limb muscle weakness (HP:0009053) | 1.71118134 |
167 | Hydroxyprolinuria (HP:0003080) | 1.71091599 |
168 | Abnormality of proline metabolism (HP:0010907) | 1.71091599 |
169 | Abnormality of the Achilles tendon (HP:0005109) | 1.68503774 |
170 | Elevated alkaline phosphatase (HP:0003155) | 1.66615667 |
171 | Ridged nail (HP:0001807) | 1.63439018 |
172 | Curly hair (HP:0002212) | 1.57242049 |
173 | Abnormality of the labia majora (HP:0012881) | 1.56461315 |
174 | Autoamputation (HP:0001218) | 1.55679081 |
175 | Hyporeflexia of lower limbs (HP:0002600) | 1.55080488 |
176 | Melanocytic nevus (HP:0000995) | 1.54804641 |
177 | Abnormality of the fingernails (HP:0001231) | 1.53109483 |
178 | Slow-growing hair (HP:0002217) | 1.49112060 |
179 | Abnormality of hair growth rate (HP:0011363) | 1.49112060 |
180 | Paralysis (HP:0003470) | 1.45421903 |
181 | Popliteal pterygium (HP:0009756) | 1.44831984 |
182 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.44579068 |
183 | Multifactorial inheritance (HP:0001426) | 1.44372540 |
184 | Selective tooth agenesis (HP:0001592) | 1.43466721 |
185 | Fine hair (HP:0002213) | 1.42054607 |
186 | Duplicated collecting system (HP:0000081) | 1.35030880 |
187 | Premature ovarian failure (HP:0008209) | 1.33521127 |
188 | Malignant hyperthermia (HP:0002047) | 1.32938840 |
189 | Everted lower lip vermilion (HP:0000232) | 1.32933491 |
190 | Conical tooth (HP:0000698) | 1.27715837 |
191 | Asthma (HP:0002099) | 1.27231287 |
192 | Hamartoma (HP:0010566) | 1.23079847 |
193 | Recurrent corneal erosions (HP:0000495) | 1.18697214 |
194 | Abnormality of the renal collecting system (HP:0004742) | 1.13112144 |
195 | Oligodontia (HP:0000677) | 1.10093311 |
196 | Nasolacrimal duct obstruction (HP:0000579) | 1.06674094 |
197 | Split foot (HP:0001839) | 1.05864357 |
198 | Xerostomia (HP:0000217) | 1.05546030 |
199 | Tetraparesis (HP:0002273) | 1.05429959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.00994070 |
2 | ERN1 | 4.81783175 |
3 | STK24 | 4.57120946 |
4 | FGFR4 | 4.47013900 |
5 | SIK1 | 4.27471841 |
6 | ERBB4 | 3.36883630 |
7 | TAOK3 | 3.28555682 |
8 | MAP3K9 | 2.86865991 |
9 | INSRR | 2.85965937 |
10 | MAP2K4 | 2.38455232 |
11 | MST1R | 2.37703381 |
12 | PIK3CG | 2.13973440 |
13 | DYRK3 | 2.09842176 |
14 | LATS1 | 2.00540256 |
15 | EPHA2 | 12.2614367 |
16 | MAPK11 | 1.95689519 |
17 | TGFBR1 | 1.89906876 |
18 | PKN2 | 1.78815912 |
19 | TRIB3 | 1.68034446 |
20 | TYK2 | 1.65466174 |
21 | IRAK4 | 1.57668593 |
22 | FLT3 | 1.54109352 |
23 | FGFR2 | 1.49812375 |
24 | PTK6 | 1.49455813 |
25 | MAP3K12 | 1.46709162 |
26 | MAP3K7 | 1.43326672 |
27 | FRK | 1.43146529 |
28 | PIM2 | 1.39350590 |
29 | ABL2 | 1.36710142 |
30 | NEK9 | 1.35216961 |
31 | DAPK2 | 1.32269411 |
32 | WNK1 | 1.25367216 |
33 | AKT3 | 1.23461906 |
34 | JAK2 | 1.21261785 |
35 | ERBB2 | 1.11521869 |
36 | MOS | 1.09690422 |
37 | MAPK15 | 1.08376747 |
38 | MAP3K14 | 1.08300980 |
39 | GRK7 | 1.08272497 |
40 | PRKAA2 | 1.05221795 |
41 | STK3 | 1.04204625 |
42 | PINK1 | 1.02715489 |
43 | ADRBK1 | 1.00504500 |
44 | KDR | 0.99608853 |
45 | JAK1 | 0.99026974 |
46 | TBK1 | 0.98274503 |
47 | PDGFRB | 0.94500981 |
48 | MET | 0.94068395 |
49 | MAP2K3 | 0.93928998 |
50 | MAP3K10 | 0.93654083 |
51 | IKBKB | 0.93008044 |
52 | EPHB1 | 0.91674118 |
53 | MAPK4 | 0.91278130 |
54 | PRKCZ | 0.88495809 |
55 | STK38L | 0.86171383 |
56 | MAP3K3 | 0.86101892 |
57 | EPHA3 | 0.83603610 |
58 | CDK6 | 0.83548572 |
59 | IRAK3 | 0.83432187 |
60 | TAOK1 | 0.81235841 |
61 | MAP3K11 | 0.80557631 |
62 | GRK6 | 0.79609488 |
63 | MAPK12 | 0.78842898 |
64 | TIE1 | 0.76018682 |
65 | MAP2K6 | 0.75203167 |
66 | PKN1 | 0.72937970 |
67 | CAMK2G | 0.72826760 |
68 | RIPK1 | 0.72619225 |
69 | DYRK1B | 0.72366667 |
70 | PDK2 | 0.70491939 |
71 | PRPF4B | 0.70058807 |
72 | PRKACG | 0.68148854 |
73 | TSSK6 | 0.67218129 |
74 | GSK3A | 0.64508763 |
75 | FGFR3 | 0.62715135 |
76 | GRK1 | 0.59006308 |
77 | PRKAA1 | 0.57478568 |
78 | STK10 | 0.57334154 |
79 | MAPK7 | 0.57301905 |
80 | CSK | 0.56138212 |
81 | BLK | 0.55074388 |
82 | PTK2 | 0.54533413 |
83 | CAMK1D | 0.54349993 |
84 | NEK6 | 0.53823005 |
85 | MAP2K1 | 0.53542236 |
86 | SGK3 | 0.51045316 |
87 | TRPM7 | 0.50388164 |
88 | TGFBR2 | 0.50150036 |
89 | IKBKE | 0.49935552 |
90 | PRKCQ | 0.48543334 |
91 | MST4 | 0.48249630 |
92 | PDPK1 | 0.48146209 |
93 | FGFR1 | 0.47132059 |
94 | MAP3K6 | 0.46769883 |
95 | MAP3K5 | 0.45289016 |
96 | MARK2 | 0.45097515 |
97 | FER | 0.43602433 |
98 | CSNK1G1 | 0.42608148 |
99 | EPHB2 | 0.42177699 |
100 | MAPKAPK3 | 0.40935052 |
101 | PAK2 | 0.40671110 |
102 | IGF1R | 0.40520088 |
103 | CSF1R | 0.40381880 |
104 | RET | 0.40089544 |
105 | MAP3K2 | 0.38958617 |
106 | MAP3K13 | 0.38472490 |
107 | ERBB3 | 0.38329768 |
108 | LATS2 | 0.38098108 |
109 | MAP2K2 | 0.37543167 |
110 | IRAK1 | 0.37465782 |
111 | CHUK | 0.35857740 |
112 | EGFR | 0.35653346 |
113 | MAP3K1 | 0.35649804 |
114 | GRK5 | 0.35085588 |
115 | EIF2AK3 | 0.34440101 |
116 | MTOR | 0.34044929 |
117 | IRAK2 | 0.33835748 |
118 | PIK3CA | 0.33452600 |
119 | PRKCG | 0.32459281 |
120 | SGK2 | 0.32088370 |
121 | EPHA4 | 0.31200713 |
122 | HCK | 0.30842566 |
123 | CDK12 | 0.30495417 |
124 | ICK | 0.30014227 |
125 | TAOK2 | 0.29572028 |
126 | PAK3 | 0.29555430 |
127 | CDK4 | 0.28794864 |
128 | PRKCE | 0.28441350 |
129 | SGK1 | 0.27283272 |
130 | ABL1 | 0.26012817 |
131 | BMX | 0.25716153 |
132 | NLK | 0.25567430 |
133 | SGK494 | 0.25439386 |
134 | SGK223 | 0.25439386 |
135 | PDK1 | 0.24994884 |
136 | PRKCA | 0.24220096 |
137 | CAMK4 | 0.23716986 |
138 | RPS6KA1 | 0.23153832 |
139 | DAPK3 | 0.22932227 |
140 | EEF2K | 0.21238661 |
141 | RPS6KB1 | 0.19221674 |
142 | MAPKAPK5 | 0.18356633 |
143 | EIF2AK2 | 0.17167653 |
144 | CAMK1 | 0.16820701 |
145 | BCR | 0.16425546 |
146 | RPS6KC1 | 0.14712157 |
147 | RPS6KL1 | 0.14712157 |
148 | TYRO3 | 0.13499453 |
149 | DYRK1A | 0.13363997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.82613790 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47025579 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29696664 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20276585 |
5 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.03197165 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97970695 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83712480 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70691132 |
9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.68244647 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62947359 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59711758 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57862531 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48304382 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41618094 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14371173 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12752630 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.12146020 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06353627 |
19 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.02302474 |
20 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.99758205 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95950388 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92223332 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92029802 |
24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.89114296 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86532546 |
26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84906609 |
27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84878207 |
28 | Long-term depression_Homo sapiens_hsa04730 | 1.80284810 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78124178 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75354692 |
31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.75221138 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75009631 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71524405 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70115869 |
35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69056207 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65496621 |
37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63828744 |
38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.62943587 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57086161 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56237378 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53879776 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52824322 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50637426 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.50508580 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.46934404 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46770687 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44008016 |
48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43692509 |
49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36537065 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33941279 |
51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33608442 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30597973 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.27728167 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26385988 |
55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26099777 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25411804 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25027652 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18313345 |
59 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15686440 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13096008 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12899805 |
62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10233236 |
63 | Tight junction_Homo sapiens_hsa04530 | 1.09254945 |
64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08631192 |
65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08517337 |
66 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06395663 |
67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06022517 |
68 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.04383661 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02339331 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98889721 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98054631 |
72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92875553 |
73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90664412 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88568763 |
75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88439326 |
76 | Endocytosis_Homo sapiens_hsa04144 | 0.83982025 |
77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83643640 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82647015 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78392562 |
80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78017586 |
81 | Lysine degradation_Homo sapiens_hsa00310 | 0.76913918 |
82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76418681 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75159354 |
84 | Phototransduction_Homo sapiens_hsa04744 | 0.74760753 |
85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73683910 |
86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72731115 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71857332 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71420525 |
89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68102689 |
90 | Platelet activation_Homo sapiens_hsa04611 | 0.67751996 |
91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67664855 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65420168 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65176419 |
94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64241311 |
95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63809065 |
96 | Renin secretion_Homo sapiens_hsa04924 | 0.62298017 |
97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61044082 |
98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60989627 |
99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57307986 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.55839054 |
101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55364228 |
102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53358024 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49443434 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48412034 |
105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46613889 |
106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46200168 |
107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45749271 |
108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44362437 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43941243 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43673423 |
111 | Mineral absorption_Homo sapiens_hsa04978 | 0.43416957 |
112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42810379 |
113 | Melanogenesis_Homo sapiens_hsa04916 | 0.41714710 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41635054 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41343595 |
116 | Adherens junction_Homo sapiens_hsa04520 | 0.40316076 |
117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40046691 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38887640 |
119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37828694 |
120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37629001 |
121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37623914 |
122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35106359 |
123 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30942760 |
124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30901533 |
125 | Influenza A_Homo sapiens_hsa05164 | 0.29053643 |
126 | Pertussis_Homo sapiens_hsa05133 | 0.28640325 |
127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28544157 |
128 | Salmonella infection_Homo sapiens_hsa05132 | 0.28138068 |
129 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27473919 |
130 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26644411 |
131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25197248 |
132 | Glioma_Homo sapiens_hsa05214 | 0.25049837 |
133 | Shigellosis_Homo sapiens_hsa05131 | 0.24678928 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.23795356 |
135 | Axon guidance_Homo sapiens_hsa04360 | 0.23747339 |
136 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23490766 |
137 | Tuberculosis_Homo sapiens_hsa05152 | 0.23103480 |
138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22071399 |
139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21737790 |
140 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20932482 |
141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20447128 |
142 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20309070 |
143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19755853 |
144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19185416 |
145 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19068340 |
146 | Salivary secretion_Homo sapiens_hsa04970 | 0.18998946 |
147 | Long-term potentiation_Homo sapiens_hsa04720 | 0.17811258 |
148 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.16221575 |
149 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16075513 |
150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15733739 |
151 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14989717 |
152 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14869385 |
153 | Apoptosis_Homo sapiens_hsa04210 | 0.14261217 |
154 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12347102 |
155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07746981 |
156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00090455 |
157 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2379101 |
158 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2187212 |
159 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2060148 |
160 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2027040 |
161 | Bladder cancer_Homo sapiens_hsa05219 | -0.1979110 |
162 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1971132 |
163 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1721611 |
164 | Amoebiasis_Homo sapiens_hsa05146 | -0.1669297 |
165 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1488066 |
166 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1403519 |
167 | Hepatitis C_Homo sapiens_hsa05160 | -0.1398545 |
168 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1385445 |
169 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1308264 |
170 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1162162 |
171 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1129960 |
172 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1064257 |
173 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0894168 |
174 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0788744 |
175 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0631647 |
176 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0529556 |
177 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0398079 |